160 related articles for article (PubMed ID: 35462754)
1. Sensitivity of Contrast-Enhanced Breast MRI vs X-ray Mammography Based on Cancer Histology, Tumor Grading, Receptor Status, and Molecular Subtype: A Supplemental Analysis of 2 Large Phase III Studies.
Endrikat J; Schmidt G; Haverstock D; Weber O; Trnkova ZJ; Barkhausen J
Breast Cancer (Auckl); 2022; 16():11782234221092155. PubMed ID: 35462754
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic efficacy of contrast-enhanced breast MRI versus X-ray mammography in women with different degrees of breast density.
Barkhausen J; Bischof A; Haverstock D; Klemens M; Brueggenwerth G; Weber O; Endrikat J
Acta Radiol; 2021 May; 62(5):586-593. PubMed ID: 32678675
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
[TBL] [Abstract][Full Text] [Related]
4. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
5. Gadobutrol-Enhanced Magnetic Resonance Imaging of the Breast in the Preoperative Setting: Results of 2 Prospective International Multicenter Phase III Studies.
Sardanelli F; Newstead GM; Putz B; Jirakova Trnkova Z; Trimboli RM; Abe H; Haverstock D; Rosenberg M
Invest Radiol; 2016 Jul; 51(7):454-61. PubMed ID: 26840494
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.
Griebsch I; Brown J; Boggis C; Dixon A; Dixon M; Easton D; Eeles R; Evans DG; Gilbert FJ; Hawnaur J; Kessar P; Lakhani SR; Moss SM; Nerurkar A; Padhani AR; Pointon LJ; Potterton J; Thompson D; Turnbull LW; Walker LG; Warren R; Leach MO;
Br J Cancer; 2006 Oct; 95(7):801-10. PubMed ID: 17016484
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
[TBL] [Abstract][Full Text] [Related]
8. Risk-benefit analysis of preoperative breast MRI in patients with primary breast cancer.
Siegmann KC; Baur A; Vogel U; Kraemer B; Hahn M; Claussen CD
Clin Radiol; 2009 Apr; 64(4):403-13. PubMed ID: 19264186
[TBL] [Abstract][Full Text] [Related]
9. Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study.
Hutton J; Walker LG; Gilbert FJ; Evans DG; Eeles R; Kwan-Lim GE; Thompson D; Pointon LJ; Sharp DM; Leach MO;
Br J Cancer; 2011 Feb; 104(4):578-86. PubMed ID: 21326245
[TBL] [Abstract][Full Text] [Related]
10. Iopromide for Contrast-Enhanced Mammography: A Systemic Review and Meta-Analysis of Pertinent Literature.
Endrikat J; Khater H; Boreham AD; Fritze S; Schwenke C; Bhatti A; Trnkova ZJ; Seidensticker P
Breast Cancer (Auckl); 2023; 17():11782234231189467. PubMed ID: 37600467
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging.
Ozülker T; Ozülker F; Ozpaçaci T; Bender O; Değirmenci H
Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988
[TBL] [Abstract][Full Text] [Related]
12. Interreader scoring variability in an observer study using dual-modality imaging for breast cancer detection in women with dense breasts.
Drukker K; Horsch KJ; Pesce LL; Giger ML
Acad Radiol; 2013 Jul; 20(7):847-53. PubMed ID: 23601952
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the diagnostic efficiency for breast cancer in Chinese women using mammography, ultrasound, MRI, and different combinations of these imaging modalities.
Shao H; Li B; Zhang X; Xiong Z; Liu Y; Tang G
J Xray Sci Technol; 2013; 21(2):283-92. PubMed ID: 23694915
[TBL] [Abstract][Full Text] [Related]
14. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
15. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
16. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.
Hagen AI; Kvistad KA; Maehle L; Holmen MM; Aase H; Styr B; Vabø A; Apold J; Skaane P; Møller P
Breast; 2007 Aug; 16(4):367-74. PubMed ID: 17317184
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI.
Wienbeck S; Fischer U; Luftner-Nagel S; Lotz J; Uhlig J
Eur Radiol; 2018 Sep; 28(9):3731-3741. PubMed ID: 29594402
[TBL] [Abstract][Full Text] [Related]
19. A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer.
Demircioglu A; Grueneisen J; Ingenwerth M; Hoffmann O; Pinker-Domenig K; Morris E; Haubold J; Forsting M; Nensa F; Umutlu L
PLoS One; 2020; 15(6):e0234871. PubMed ID: 32589681
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
